WE ARE CONCEIVING A FUTURE WHERE ANYONE WHO WANTS TO HAVE A CHILD CAN HAVE A HEALTHY ONE

Our mission is fueled by hope and accomplished with care. In the pursuit of a better tomorrow, we’re pioneering some of the most advanced fertility solutions known to science. Our company develops new technologies and procedures that improve conception rates and keep mothers safe. Our high-level of clinical expertise is matched only by the invaluable support we extend to those who work with us. Simply put, we are expanding the potential of reproductive healthcare, so that families everywhere can share their love with a new generation.

AN INNOVATIVE APPROACH TO FERTILITY HEALTH

Fertility healthcare is an interconnected process that starts with a coverage plan, continues with medical treatments, and ends when a new child becomes a part of the family. We are innovating across all touch points of this experience. Our benefit packages offer access to exclusive treatment solutions developed by our doctors and scientists. Not only are we helping more women conceive, we’re improving the likelihood of single child pregnancies. Now, more couples can have the family they’ve hoped for while avoiding the costly health risks associated with birthing twins or triplets. We also offer adoption resources to families who are beyond the reach of medical interventions. By connecting people with coverage featuring complete price transparency, scheduling assistance, and preferred appointment times at top clinics, we’re positioning ourselves at the leading edge of reproductive healthcare.

COMMITTED TO YOUR SUCCESS

We are unified by our commitment to the patients we serve. For our team, infertility isn’t just a medical issue--it’s personal. That’s why we’re providing smart fertility solutions and increasing medical access to families everywhere.

Peter Anevski
Chief Financial & Operating Officer
plus

Pete joined WebMD in 1999 and served as senior management in a number of finance and operations roles, becoming the company's CFO in 2013. He played an integral role in WebMD’s growth in revenue and profitability through implementation of changes in pricing and market positioning, programmatic strategy and execution and other finance and operating disciplines that led to the company's improved financial performance. Prior to joining WebMD, Pete was in corporate accounting at Toys "R" Us and a CPA with Wiss &Co, LLPminus

David Schlanger
Chief Executive Officer
plus

David Schlanger has been a healthcare executive for more than 25 years and most recently was the CEO of WebMD from 2013 to 2016. During his tenure leading WebMD, the company achieved record levels of revenue and profitability, saw WebMD's and Medscape's audiences grow to record highs and maintained their positions as the industry leaders in providing health information and digital services to health care professionals, consumers, and corporate employees. Prior to his time as CEO, Schlanger held various other senior positions at WebMD, including leading the strategy, M&A and business development functions. Schlanger earned a Juris Doctor from The University of Michigan School of Law, and a Bachelor of Arts in Economics from Georgetown University.minus

Karin Ajmani
President, Healthcare Services
plus

Bringing a multitude of specialty health and managed care experience, Karin is leading Progyny’s employer benefits products. Her mission is to expand employer coverage of infertility services by providing a solution that is a win/win for employers, patients and clinicians. Prior to joining Progyny, Karin was CEO of US Imaging for eight years, and previously served as CEO of CarePlus Health Plan, a managed care plan in NY, where she led the organization from inception in 1996 through its sale in 2005. Karin also serves on the boards of Autism Learning Partners, a national autism provider services company, and Citra Health, a leading healthcare technology company. In 2017, Karin was selected as one of New York Business Journal’s Women of Influence. She has a master’s in Public Health from Columbia Univ. and is a graduate of the Univ. of Pittsburgh. minus

Norm Payson
Norman C. Payson, M.D.
plus

Payson is currently the chairman of the board of trustees for the City of Hope, and board member of Evolent Health, Inc. and Apria Healthcare Group, Inc. He has more than 30 years of experience as a chief executive officer for multiple healthcare organizations and is well known for his knowledge on engaging physicians and hospitals in their participation in health plans. Payson is a graduate of the Massachusetts Institute of Technology and received his medical degree from Dartmouth Medical School.minus

David Schlanger
Chief Executive Officer
plus

David Schlanger has been a healthcare executive for more than 25 years and most recently was the CEO of WebMD from 2013 to 2016. During his tenure leading WebMD, the company achieved record levels of revenue and profitability, saw WebMD's and Medscape's audiences grow to record highs and maintained their positions as the industry leaders in providing health information and digital services to health care professionals, consumers, and corporate employees. Prior to his time as CEO, Schlanger held various other senior positions at WebMD, including leading the strategy, M&A and business development functions. Schlanger earned a Juris Doctor from The University of Michigan School of Law, and a Bachelor of Arts in Economics from Georgetown University.minus

Fred Cohen,M.D.,D.Phil.
TPG Biotech
plus

Prior to joining TPG Biotechnology in 2001, Dr. Fred Cohen, M.D., D.Phil., was a Professor of medicine, cellular and molecular pharmacology, biochemistry and biophysics and pharmaceutical chemistry at UCSF. In this context, he was Chief of the Division of Endocrinology and Metabolism and directed an active research program in the areas of prion biology, structure based drug design, bioinformatics and heteropolymer chemistry. Dr. Cohen is a Fellow of the Institute of Medicine of the National Academies, the American Academy of Arts and Sciences, American College of Physicians, a member of the American Society for Clinical Investigation and the Association of American Physicians, and the recipient of several awards and honors including the Burroughs-Wellcome New Initiatives in Malaria Award, the L$ctrlH Science Pour L’Art Prize (shared with Stanley Prusiner), a Searle Scholars Award and Young Investigator Awards from the Endocrine Society and the Western Society for Clinical Investigation. He graduated magna cum laude from Yale University in 1978 and received his D.Phil from Oxford University as a Rhodes Scholar in 1980, his M.D. from Stanford Medical School as an American Cancer Society Postdoctoral Fellow in 1984 and his internal medicine and endocrinology training at UCSF. He joined TPG in 2001 to initiate TPG’s venture efforts in biotechnology and life sciences. He currently serves on the board of directors of: Acumen, Inc.; BioCryst, Inc. (Nasdaq: BCRX); CareDx, Inc. (Nasdaq: CDNA); Five Prime Therapeutics, Inc. (Nasdaq: FPRX); Genomic Health, Inc. (Nasdaq: GHDX); Rapid Micro Biosystems Inc.; Roka Bioscience, Inc. (Nasdaq: ROKA); Tandem Inc. (Nasdaq: TNDM); and Veracyte, Inc. (Nasdaq: VCYT).minus

Beth Seidenberg, M.D.
Kleiner Perkins Caufield & Byers
plus

Dr. Beth Seidenberg, M.D., joined Kleiner Perkins Caufield & Byers in May 2005 to work in the life sciences area. Beth was formerly the Senior Vice President, Global Development, and Chief Medical Officer at Amgen. Prior to joining Amgen, Beth was a senior executive in research and development at Bristol-Myers Squibb and Merck & Co. She began her career in basic and clinical research at the National Institutes of Health specializing in immunology and infectious diseases. In total, she introduced 10 innovative products to market and achieved over 40 regulatory approvals (including new indications and formulations) on a worldwide basis. She is currently on the Board of Directors of 3-V Biosciences, Arresto Biosciences, BioCryst Pharmaceuticals, Breathe Technologies, Epizyme, iPierian, Inc, and RedBrick Health. Her primary focus is in novel therapeutics to treat unmet medical needs.minus

Simeon George, M.D.
SR One
plus

Dr. Simeon George, M.D., joined SR One in 2007 and leads SR One’s investment activities on the West Coast. Prior to joining SR One, Simeon was a consultant at Bain & Company and an investment banker at Goldman Sachs and Merrill Lynch. Simeon is a member of the Board of Directors of Anaphore, Auxogyn, Inc., Genocea Biosciences, HTG Molecular, Principia Biosciences and Semprus BioSciences. Simeon received his B.A. in Neuroscience from the Johns Hopkins University, where he graduated Phi Beta Kappa. Simeon received his MD from the University of Pennsylvania School of Medicine and his M.B.A. (Mayer Scholar) from the Wharton School of the University of Pennsylvania.minus

Linda Mintz
Care Finders Total Care, LLC
plus

Linda Mintz is the Co-Chairman of Care Finders Total Care, LLC, a leading home health care company with 5 offices in NJ, and over 2000 employees. Ms Mintz is also a managing partner at LCP Advisors, LLC, a business advisory firm that provides strategic growth strategies, merger and acquisitions advisory services, exit strategies, and operational, transactional and financing assistance to companies at all stages of business development, from start ups, to middle market and mature companies looking for an exit. Ms Mintz has represented clients in a variety of industries including consumer products, fashion, healthcare, financial services, specialty chemicals, hospitality, real estate and technology. Prior to forming LCP Advisors, Ms Mintz was a corporate lawyer at Weil, Gotshal & Manges and a partner at Greenberg Traurig, and has over 20 years of transactional experience in evaluating, structuring, negotiating and completing mergers, acquisitions, debt and equity offerings and restructuring transactions for both public and private companies. Ms. Mintz also founded and operated a health-oriented, specialty snack food company from 1991-1999. Ms. Mintz has also held investment banking and private equity positions with Citibank, N.A., and Lioness Capital Partners, LLC. She has been a frequent speaker at trade business conferences on growth strategies, capital raising, mergers and acquisitions and exit strategies for privately held companies. Ms. Mintz graduated with a Bachelor of Science and Management from Tulane University School of Business and earned her Doctorate of Jurisprudence from University of Miami.minus

Kathy Harris
Sharecare, INC.
plus

Kathy Harris serves as Senior Vice President Corporate Development of Sharecare, Inc., an interactive, social Q&A platform designed to greatly simplify the search for quality healthcare information and help consumers live their healthiest life. Prior to Sharecare, she was a General Partner at Noro-Moseley Partners, the oldest and one of the largest venture capital firms in the Southeastern US. She led the Firm’s business development efforts throughout the Southeast and Texas and also focused on its investment activities in the healthcare industry. Prior to Noro-Moseley, Kathy was a Partner at Technology Ventures, a venture capital firm focused on Internet and e-commerce companies, the National Marketing Manager of Sirrom Capital Corporation, where she oversaw all business development and loan origination activities and Senior Vice President of the Investment Banking Group at J.C. Bradford & Co. (now UBS). Over her career, she has invested in early and growth stage companies in a broad array of industries and has been involved in more than 100 investment banking transactions totaling over $2 billion. Kathy started her career at KPMG. She serves on the Boards of the Clemson University Research Foundation, the Health Care Advisory Board of Vanderbilt’s Owen Graduate School of Management and The Women's Leadership Board at Harvard's Kennedy School of Government.minus

Dr. Fahimeh Sasan
Chief Medical Advisor at Progyny
plus

Fahimeh Sasan, DO is a practicing OBGYN (Obstetrician & Gynecologist) in New York, NY. Dr. Sasan graduated from University of North Texas Health Science Center College of Osteopathic Medicine in 2006 and has been in practice for 8 years. She currently practices at Mount Sinai School of Medicine and is affiliated with Elmhurst Hospital Center, Mount Sinai Hospital of Queens and The Mount Sinai Medical Center. Dr. Sasan accepts multiple insurance plans including Aetna, MVP Health Plan and Empire Blue Cross Blue Shield. In addition to English, Dr. Sasan's practice supports these languages: French, Spanish, Korean, Arabic, Polish, Vietnamese, Russian, Italian and German.minus

Dr. George M. Grunert
MD
plus

Dr. Grunert has over 30 years of experience in treating patients with infertility. He is the founder and program director of the longest ongoing IVF program in the Southwest. Raised in San Antonio, he came to Houston to attend Rice University. After graduating from Rice at the age of 19, he stayed in Houston to attend medical school at Baylor College of Medicine. After receiving his M.D. degree, he completed his residency in obstetrics and gynecology at the Naval Regional Medical Center, Oakland and Fellowship in Reproductive Endocrinology at the University of California San Francisco. Returning to Houston to begin private practice, he established the IVF program at the Woman’s Hospital of Texas and Houston Fertility Specialists. He has a specific interest in fertility preservation and reproductive genetics. He remained in the U.S. Navy Reserve and was recalled to active duty for Operation Desert Storm. He retired as a Captain, Medical Corps, USNR. Dr. Grunert is proud and honored to have helped many patients from around the world realize there dream of having a family. He believes in a personal individualized practice approach to the evaluation, diagnosis, and treatment of infertility. When asked his practice philosophy, Dr. Grunert says “I want to give each patient hope and honest accurate information about their path to parenthood. I believe in building families one baby step at a time."minus

Dr. Francisco Arredondo
RMA of Texas
plus

Doctor Francisco Arredondo is a respected and experienced clinician and has published numerous papers and textbook chapters on infertility and recurrent pregnancy loss. In addition, he has presented research findings and scientific data at both national and international meetings. He emphasizes a simplified and individualized approach in his treatments, bearing in mind the specific couple’s social, medical, financial and emotional circumstances.minus

Dr. F. Nicholas Shamma
IVF Michigan
plus

Dr F. Nicholas Shamma is a founding member of IVF Michigan Fertility Center and one of the leading reproductive endocrinologists and infertility specialists in Michigan and Ohio. Dr F. Nicholas Shamma is American Board Certified in both Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. He has performed over 8,000 IVF cases and has helped several thousand couples achieve their dreams of parenthood. Dr F. Nicholas Shamma has over 150 publications and abstracts in the fields of obstetrics, gynecology, and infertility. One of his papers on the incidence of intra-amniotic infection, and causes of preterm delivery of twins is one of the 50 most quoted papers in the field of obstetrics and gynecology according to the American Journal of Obstetrics and Gynecology. Dr F. Nicholas Shamma is a very caring and an expert physician that understands not only the medical, but also the emotional toil of infertility on his patients. He offers them personalized care and compassion. This explains his success rates (one of the highest in the USA) in IVF, and also explains why he performs more IVF cases than any other specialist in the state of Michigan.minus

Dr. Brad Kolb
HRC Fertility
plus

Bradford Kolb, M.D. received his undergraduate and graduate degrees from the University of California, Irvine. He then completed his residency in Obstetrics and Gynecology at Northwestern University and a fellowship in Reproductive Endocrinology & Infertility at the University of Southern California, receiving board certification in both fields. Dr. Kolb currently holds the position of Assistant Clinical Professor in the Department of Obstetrics and Gynecology at the University of Southern California School of Medicine. As a physician, he specializes in the care of complex fertility problems at HRC Fertility, where he serves as the Medical Director. Under his guidance, he has helped improve HRC’s donor pregnancy rate to over 70% per embryo transfer in 2010 alone. Dr. Kolb is known for his expertise in complex reproductive matters and is one of the largest providers of egg donation and surrogacy in the United States, while helping people from over 35 countries each year. His practice is also known for helping to develop and implement cutting-edge technologies in the genetic screening of embryos, along with new laboratory technologies and highly efficient treatment in general.minus

Dr. Bill Yee
RPMG
plus

Bill Yee, M.D. completed a residency at the Los Angeles County, University of Southern California Hospital in Los Angeles and then a fellowship In Reproductive Endocrinology at USC. Dr. Yee is Board Certified in both OB/GYN and Reproductive Endocrinology/Infertility. He has been a pioneer in the field of in vitro fertilization since 1982, and his contributions include the first successful frozen embryo transfer resulting in a healthy baby in the United States. Dr. Yee is well known for his expertise in the field of ultrasound. He is also noted as the lead author of Transvaginal Sonography in Infertility. Also his pioneering work to save the lowland gorilla from extinction resulted from the first successful in vitro fertilization in this species. Dr. Yee has served and held numerous leadership positions including president of the Society for Assisted Reproductive Technology (SART), board member of the American Society for Reproductive Medicine ( ASRM), and an active deputy commissioner of the College of American Pathologists (CAP) for the past twenty years which regulates IVF labs in the United States. In 1996, he co-founded the Pacific Society for Reproductive Medicine and is a permanent member of their Executive Council. When not working Dr. Yee enjoys golf, travel and exotic sports cars.minus

Dr. Michael Glassner
Main Line Fertility
plus

Dr. Glassner is a founding partner and the medical director at Main Line Fertility and Reproductive Medicine. He also is a clinical professor at Drexel School of Medicine and clinical educator at Jefferson Medical School. He is also the founding Director of the Center for Reproductive Medicine at Bryn Mawr Hospital and under his tutelage has become a leading IVF center in the area. He graduated from Albany Medical College after completing both medical school and college in six years. Dr. Glassner served his residency at The Medical College of Pennsylvania and performed his fellowship in Reproductive Medicine and Infertility at The Hospital of the University of Pennsylvania. He has been in private practice treating infertility patients for almost 25 years.minus

Dr. Alan Copperman
RMA of New York
plus

Dr. Alan Copperman is Director of the Division of Reproductive Endocrinology and Infertility as well as the Vice-Chairman of the Department of Obstetrics, Gynecology, and Reproductive Science at Mount Sinai Medical Center. He is a Clinical Professor of Obstetrics, Gynecology, and Reproductive Science at the Mount Sinai School of Medicine. Dr. Copperman also serves as Medical Director of RMA of New York. He is an experienced and respected clinician and has published numerous award-winning papers and textbook chapters on egg freezing, infertility, in vitro fertilization, and pelvic surgery. In addition, he has presented research findings and scientific data at both national and international meetings. Dr. Copperman is frequently quoted in the media, both in print (The New York Times, Daily News, Parenting Magazine, etc) and on local and national television and news shows (including Anderson Cooper 360 and 20/20). New York Magazine has recognized Dr. Copperman as one of its Best Doctors fourteen years in a row, and Castle Connolly and SuperDocs have annually recognized Dr. Copperman as one of the top fertility doctors. The American Fertility Association awarded him its 2003 Family Building Award. Dr. Copperman received his undergraduate degree from the University of Pennsylvania and his medical degree from New York Medical College. After earning his degree in medicine, Dr. Copperman completed residency in OB/GYN at Yale-New Haven Hospital, then continued his training at Mount Sinai Medical Center in New York as the Martin J. Clyman Fellow in Reproductive Endocrinology. Dr. Copperman is board certified in reproductive endocrinology and infertility as well as in obstetrics and gynecology. He is a fellow of the American College of Obstetricians and Gynecologists and of the American Society for Reproductive Medicine.minus

Dr. Daniel Shapiro
Reproductive Biology Associates
plus

Dr. Daniel Shapiro Reproductive Biology Associates Daniel B. Shapiro, M.D. joined Reproductive Biology Associates in 1995. A native of Miami, Florida, he graduated Magna cum laude, Phi Beta Kappa from Bowdoin College in Brunswick, Maine. He then went on to medical school at Emory University School of Medicine in Atlanta and it was during this training that Dr. Shapiro first became interested in reproductive medicine by doing a research project with RBA in 1987. Dr. Shapiro completed fellowship training in Reproductive Endocrinology and Infertility at the University Of Connecticut School Of Medicine in 1995. Dr. Shapiro is board-certified in both Obstetrics and Gynecology and Reproductive Endocrinology/Infertility. He is a member of the American Society for Reproductive Medicine (ASRM), the American College of Obstetrics and Gynecology (ACOG), and the Society of Reproductive Endocrinologists.minus

Dr. Serena Chen
IRMS
plus

Serena H. Chen, M.D. graduated from Brown University in Providence Rhode Island. She attended Duke University School of Medicine in Durham, North Carolina, and then trained in Gynecology and Obstetrics and Reproductive Endocrinology and Infertility at the Johns Hopkins Hospital in Baltimore, Maryland. Dr. Chen serves as Director for the Division of Reproductive Medicine in the Department of Obstetrics and Gynecology at Saint Barnabas Medical Center, and the Institute for Reproductive Medicine and Science at Saint Barnabas, and is a Clinical Associate Professor at Rutgers, UMDNJ Medical School and the St George’s University School of Medicine. She is honored that she has been voted by her peers to be a Top Doctor in the NJ Monthly survey, Castle Connelly, US News and World Report, Inside Jersey Magazine, and NY Magazine in reproductive medicine, infertility and cancer for her work in promoting Oncofertility awareness. Dr. Chen loves empowering her patients with information and ideas about their mental and physical health in an interesting, accessible and practical way. She feels privileged to be at a program that is a leader in Assisted Reproductive Technology (ART), IUI, IVF, Single Embryo Transfer, LGBT family building, egg freezing and PGD (Preimplantation Genetic Diagnosis), offering individualized counseling, advice and treatment for a wide spectrum of reproductive issues. She strongly supports her patients’ right to be informed and involved in their treatment decisions and is an advocate of access to reproductive care for all.minus

Dr. David Sable
plus

David Sable MD directs healthcare and life science investing for the Special Situations Funds and is portfolio manager of the Special Situations Life Sciences Fund. After graduating from the Wharton School and the University of Pennsylvania School of Medicine, he trained in obstetrics and gynecology at New York Hospital - Cornell Medical Center, and in reproductive endocrinology at the Brigham and Women's Hospital. He co-founded and served as director of the Institute for Reproductive Medicine and Science at Saint Barnabas Medical Center in New Jersey, and was founder and CEO of Assisted Reproductive Medical Technologies, a private company that was acquired in 1999. After leaving clinical medicine, Dr. Sable managed a proprietary healthcare portfolio at Deutsche Bank before joining the Special Situations Funds. Dr. Sable is an adjunct in the department of biology at Columbia University, and teaches “Entrepreneurship in Biotechnology” at Columbia’s Graduate School of Arts and Sciences. He has lectured on healthcare investing, policy, and biotechnology business development at the Wharton School, NYU, Rockefeller University and Rutgers; has delivered keynote addresses to the American Fertility Society, the Texas Fertility Society and the Mexican Fertility Society; and appeared on the CBS Morning News, ABC World News Tonight, NY1 News and PBS’ Nova. He serves on the board of directors for the nonprofit organization Resolve, and is a member of the clinical advisory board for Ovascience, a Massachusetts-based public company developing advanced treatments for infertility. In addition to his academic publications, he has written for the Newark Star-Ledger, Yoga Journal, Xconomy, Genetic Engineering and Biotechnology News, Wharton Magazine, the Columbia Spectator, and writes the “…and other secrets of the buy side” and the "...and other things I learned as an IVF doc" blogs for Forbes Magazine.minus

Dr. Gerard Letterie
Seattle Reproductive Medicine
plus

Dr. Letterie brings decades of esteemed service, research, and technology design to SRM with the merger of Northwest Center for Reproductive Sciences. A board certified Reproductive Endocrinologist, and a fellow and diplomat in the American College of Obstetricians and Gynecologists and the American College of Physicians, Dr. Letterie has authored more than 125 scientific articles and 25 chapters and monographs on infertility and IVF (In Vitro Fertilization). He is an ad-hoc editor for several journals including Fertility and Sterility, Human Reproduction, American Journal of Obstetrics, Gynecology and Obstetrics, Gynecology Clinical Genetics, Journal of Pelvic Surgery, Drug, and the Journal of Reproductive Medicine. The second edition of his text “Surgery, Assisted Reproductive Technology, and Infertility” continues to serve as a reference for practitioners in infertility and reproductive endocrinology.minus

Dr. Angeline Beltsos
Vios Fertility
plus

Dr. Angeline Beltsos is the CEO and Medical Director of Vios Fertility Institute Chicago. She is board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI), practicing medicine since 1991. Dr. Beltsos completed her residency in Obstetrics and Gynecology at Loyola University in 1995 followed by a fellowship in REI at Washington University in St. Louis, Missouri, completed in 1997. Dr. Beltsos is also the Clinical Research Division Director of Vios and participates in a number of research projects and scientific publications. She has received numerous awards in teaching and has been honored as “Top Doctor” from Castle Connelly for several years. She is a popular speaker, both nationally and internationally, and a frequent media resource on the topic of infertility. She is the executive chairperson for the Midwest Reproductive Symposium International, an international conference of fertility experts. As the REI Division Education Director for the Obstetrics and Gynecology residency programs of Illinois Masonic Medical Center, Lutheran General Hospital, and St. Joseph’s Hospital Chicago, Dr. Beltsos helps educate future OB/GYN doctors. She is a Clinical Assistant Professor for the Department of Obstetrics and Gynecology at University of Illinois at Chicago.minus

Dr. Louis Weckstein
RSC Bay Area
plus

Dr. Weckstein received his training in infertility at University of California-Irvine in 1988 with one of the most successful IVF teams in the country at that time. After establishing a successful OB/GYN private practice in Southern California, he returned to training that included special emphasis on assisted reproductive technologies. He is certified by the American Board of Obstetrics and Gynecology and is a member of the Society for Assisted Reproductive Technology and the Society for Reproductive Surgeons. Dr. Weckstein has served on the board of directors of the Pacific Coast Reproductive Society and was a past California representative to the National Advisory Council of the American Society of Reproductive Medicine. Dr. Weckstein has authored more than 50 publications and abstracts with a focus on IVF and Egg Donation. He serves as a special reviewer for the infertility journal “Fertility and Sterility.” He is medical and IVF director at RSC.minus